BUZZ-Australia's Tetratherix hits four-week high on supply deal with Henry Schein

Reuters01-19
BUZZ-Australia's Tetratherix hits four-week high on supply deal with Henry Schein

** Shares of Australia's Tetratherix TTX.AX rise 4.4% to A$3.55, their highest level since December 22

** Clinical products co executes global distribution & supply agreement with Henry Schein HSIC.O, a provider of healthcare solutions to office-based dental and medical practitioners

** Says agreement provides a pathway for first Tetratherix product launch in the United States and other major markets

** Stock up 8.2% YTD

(Reporting by Shruti Agarwal in Bengaluru)

((Shruti.Agarwal@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment